Cargando…

Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn’s Disease or Ulcerative Colitis in the United States

BACKGROUND: Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), affects an estimated 1.6 million US adults, and results in humanistic and economic burden even among mild patients, which grows with increasing disease activity. METHODS: Gastroenterologists and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Zhijie, Muser, Erik, Izanec, James, Lukanova, Rina, Kershaw, James, Roughley, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Observations and Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802455/ https://www.ncbi.nlm.nih.gov/pubmed/36777416 http://dx.doi.org/10.1093/crocol/otac023

Ejemplares similares

Rectal Urgency Among Patients With Ulcerative Colitis or Crohn’s Disease: Analyses from a Global Survey
por: Ha, Christina, et al.
Publicado: (2023)

Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn’s Disease Initiated on Biologic or Conventional Agents
por: Pilon, Dominic, et al.
Publicado: (2022)

Persistence, Dosing, and Other Treatment Patterns Among Crohn’s Disease Patients Initiating Biologics in United States
por: Teeple, Amanda, et al.
Publicado: (2021)

Indirect costs of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. A systematic review
por: Kawalec, Paweł
Publicado: (2016)

Inflammatory Response in Patients With Crohn’s Disease Compared With Ulcerative Colitis: Secondary Results of a Prospective Pilot Study
por: El-Hussuna, Alaa, et al.
Publicado: (2022)

Burden of Fatigue Among Patients with Ulcerative Colitis and Crohn’s Disease: Results from a Global Survey of Patients and Gastroenterologists
por: Regueiro, Miguel, et al.
Publicado: (2022)

Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations
por: Le Berre, Catherine, et al.
Publicado: (2020)

Clinical Outcome Assessments in Pediatric Patients With Ulcerative Colitis and Crohn’s Disease Receiving Biologics: A Retrospective Cohort Study
por: Hunter, Theresa, et al.
Publicado: (2022)

Extraintestinal Manifestations and Other Comorbidities in Ulcerative Colitis and Crohn Disease: A Danish Nationwide Registry Study 2003–2016
por: Vadstrup, Kasper, et al.
Publicado: (2020)

Prevalence and Factors Associated With Fecal Urgency Among Patients With Ulcerative Colitis and Crohn’s Disease in the Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease
por: Dawwas, Ghadeer K, et al.
Publicado: (2021)

Questionnaire Survey for Inflammatory Bowel Disease Patients in Japan; A Web-Based Japan, Crohn’s Disease, Ulcerative Colitis, Patients Survey
por: Matsumoto, Takayuki, et al.
Publicado: (2023)

All ileo-cecal ulcers are not Crohn’s: Changing perspectives of symptomatic ileocecal ulcers
por: Toshniwal, Jay, et al.
Publicado: (2017)

Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn’s Disease: Post Hoc Analyses of VISIBLE Studies
por: Sandborn, William J, et al.
Publicado: (2023)

Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis
por: Panaccione, Remo, et al.
Publicado: (2023)

Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis
por: Kerur, Basavaraj, et al.
Publicado: (2017)

Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis
por: Klepp, Pasquale, et al.
Publicado: (2018)

Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis
por: Dubinsky, Marla C, et al.
Publicado: (2022)

Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn’s Disease and 2 Years in Ulcerative Colitis
por: Abraham, Bincy P, et al.
Publicado: (2022)

Increased Mortality and Healthcare Costs Upon Hospital Readmissions of Ulcerative Colitis Flares: A Large Population-Based Cohort Study
por: Weissman, Simcha, et al.
Publicado: (2021)

Disease activity, quality of life, and indirect costs of ulcerative colitis in Poland
por: Kawalec, Paweł, et al.
Publicado: (2017)

Full, Partial, and Modified Permutations of the Mayo Score: Characterizing Clinical and Patient-Reported Outcomes in Ulcerative Colitis Patients
por: Naegeli, April N, et al.
Publicado: (2021)

Telemonitoring of Crohn’s Disease and Ulcerative Colitis (TECCU): Cost-Effectiveness Analysis
por: Del Hoyo, Javier, et al.
Publicado: (2019)

Efficacy and safety of stellate ganglion block in chronic ulcerative colitis
por: Zhao, Hong-Ying, et al.
Publicado: (2017)

Short-term effectiveness of golimumab for ulcerative colitis: Observational multicenter study
por: Bosca-Watts, Marta Maia, et al.
Publicado: (2016)

Clinical course of ulcerative colitis patients who develop acute pancreatitis
por: Kim, Jong Wook, et al.
Publicado: (2017)

Outcomes of a drug shortage requiring switching in patients with ulcerative colitis
por: van Langenberg, Daniel R, et al.
Publicado: (2020)

Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States
por: Afzali, Anita, et al.
Publicado: (2023)

Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States
por: Hong, Simon J, et al.
Publicado: (2021)

Golimumab in real-world practice in patients with ulcerative colitis: Twelve-month results
por: Teich, Niels, et al.
Publicado: (2020)

Relationship between clinical features and intestinal microbiota in Chinese patients with ulcerative colitis
por: He, Xu-Xia, et al.
Publicado: (2021)

Effectiveness and Durability of Ustekinumab Therapy With or Without Immunomodulators for Ulcerative Colitis Patients in Japan
por: Aoki, Yasuhiro, et al.
Publicado: (2022)

Perioperative Venous Thromboembolism in Ulcerative Colitis: A Multicenter Prospective Study in Japan
por: Itabashi, Michio, et al.
Publicado: (2021)

Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative Colitis
por: Sharma, Shreyak, et al.
Publicado: (2023)

Assessing Histological Inflammatory Activity in Patients With Ulcerative Colitis: A Diagnostic Accuracy Study Testing Fecal Biomarkers Lactoferrin and Calprotectin
por: Langhorst, Jost, et al.
Publicado: (2020)

Metabolic syndrome attenuates ulcerative colitis: Correlation with interleukin-10 and galectin-3 expression
por: Jovanovic, Marina, et al.
Publicado: (2019)

Clinical characteristics and prognosis of patients with ulcerative colitis that shows rectal sparing at initial diagnosis
por: Choi, Yong-Sung, et al.
Publicado: (2021)

Overweight and abdominal fat are associated with normal bone mineral density in patients with ulcerative colitis
por: Lopes, Mirella Brasil, et al.
Publicado: (2022)

Real-World Long-Term Remission Maintenance for 10 Years With Thiopurines in Ulcerative Colitis
por: Matsumoto, Satohiro, et al.
Publicado: (2021)

Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study
por: Perin, Ramir Luan, et al.
Publicado: (2022)

Knowledge and attitudes towards the use of histological assessments in ulcerative colitis by gastroenterologists vs pathologists
por: Pudipeddi, Aviv, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ts5cft752h6upmhhe3cp2b033d